The Global Partnership on Drug Policies and Development (GPDPD) aims to foster international drug policy approaches that are based on sustainable development and the improvement of public health. The project cooperates closely with interested governments and international partner organisations to achieve its objectives. Commissioned by the German Federal Ministry for Economic Cooperation and Development (BMZ) and under the political patronage of the Federal Republic’s Drug Commissioner, one main focus of GPDPD’s work is to promote the international drug policy discourse. This applies especially at United Nations level but also to the European Union framework, the OSCE and G7. The project provides developing and emerging countries in particular with the opportunity to feed their development policy priorities into the debate of the international community.
Since 2010, international drug policy has been accompanied by a reform debate of increasing intensity. Alternative development and public health-oriented approaches are becoming ever more popular among governments as well as international and regional organizations. The UN General Assembly Special Session on the World Drug Problem (UNGASS 2016) in April 2016 represents an important turning point in international drug policy. The resolutions adopted at UNGASS 2016 will constitute the framework for modelling and implementing innovative drug policies over the years ahead.
GPDPD prepared the UNGASS session jointly with partner governments in the EU, Africa and Latin America. On behalf of the German Federal Government, it identified joint development-focused and health-oriented positions amongst partners and fed them into the UNGASS outcome document. GPDPD has built up alliances with several agents in order to present their aligned positions at the United Nations General Assembly. The governments of Great Britain, Colombia, Morocco, Myanmar, Norway, Peru and Thailand, for example, have been partners in shaping the UNGASS process and formulating joint positions.